CALIDA Holding Valuation
Is CALNZ undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
5/6Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of CALNZ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: CALNZ (CHF24.2) is trading below our estimate of fair value (CHF53.38)
Significantly Below Fair Value: CALNZ is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for CALNZ?
Key metric: As CALNZ is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
What is CALNZ's PS Ratio? | |
---|---|
PS Ratio | 0.6x |
Sales | CHF 292.77m |
Market Cap | CHF 182.56m |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 0.8x |
Enterprise Value/EBITDA | 44.4x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does CALNZ's PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 0.8x | ||
MUL Mulberry Group | 0.5x | n/a | UK£82.7m |
SOS Sosandar | 0.5x | 8.6% | UK£23.0m |
BRBY Burberry Group | 1.2x | 1.9% | UK£3.2b |
TUNE Focusrite | 0.8x | 0.1% | UK£141.8m |
CALNZ CALIDA Holding | 0.6x | -0.009% | CHF 182.6m |
Price-To-Sales vs Peers: CALNZ is good value based on its Price-To-Sales Ratio (0.6x) compared to the peer average (0.8x).
Price to Sales Ratio vs Industry
How does CALNZ's PS Ratio compare vs other companies in the European Luxury Industry?
16 Companies | Price / Sales | Estimated Growth | Market Cap |
---|---|---|---|
16 Companies | Estimated Growth | Market Cap | |
---|---|---|---|
Price-To-Sales vs Industry: CALNZ is good value based on its Price-To-Sales Ratio (0.6x) compared to the European Luxury industry average (0.7x).
Price to Sales Ratio vs Fair Ratio
What is CALNZ's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 0.6x |
Fair PS Ratio | 0.9x |
Price-To-Sales vs Fair Ratio: CALNZ is good value based on its Price-To-Sales Ratio (0.6x) compared to the estimated Fair Price-To-Sales Ratio (0.9x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | CHF 24.20 | CHF 30.50 +26.0% | 11.5% | CHF 34.00 | CHF 27.00 | n/a | 2 |
Nov ’25 | CHF 25.75 | CHF 30.50 +18.4% | 11.5% | CHF 34.00 | CHF 27.00 | n/a | 2 |
Oct ’25 | CHF 29.15 | CHF 30.50 +4.6% | 11.5% | CHF 34.00 | CHF 27.00 | n/a | 2 |
Sep ’25 | CHF 28.40 | CHF 31.00 +9.2% | 12.9% | CHF 35.00 | CHF 27.00 | n/a | 2 |
Aug ’25 | CHF 29.20 | CHF 31.00 +6.2% | 12.9% | CHF 35.00 | CHF 27.00 | n/a | 2 |
Jul ’25 | CHF 30.90 | CHF 31.50 +1.9% | 11.1% | CHF 35.00 | CHF 28.00 | n/a | 2 |
Jun ’25 | CHF 31.50 | CHF 31.50 0% | 11.1% | CHF 35.00 | CHF 28.00 | n/a | 2 |
May ’25 | CHF 29.05 | CHF 31.50 +8.4% | 11.1% | CHF 35.00 | CHF 28.00 | n/a | 2 |
Apr ’25 | CHF 29.10 | CHF 31.50 +8.2% | 11.1% | CHF 35.00 | CHF 28.00 | n/a | 2 |
Mar ’25 | CHF 28.55 | CHF 32.50 +13.8% | 13.8% | CHF 37.00 | CHF 28.00 | n/a | 2 |
Feb ’25 | CHF 27.25 | CHF 35.00 +28.4% | 20.0% | CHF 42.00 | CHF 28.00 | n/a | 2 |
Jan ’25 | CHF 29.55 | CHF 38.00 +28.6% | 10.5% | CHF 42.00 | CHF 34.00 | n/a | 2 |
Dec ’24 | CHF 28.50 | CHF 45.00 +57.9% | 6.7% | CHF 48.00 | CHF 42.00 | n/a | 2 |
Nov ’24 | CHF 25.50 | CHF 45.00 +76.5% | 6.7% | CHF 48.00 | CHF 42.00 | CHF 25.75 | 2 |
Oct ’24 | CHF 30.30 | CHF 45.00 +48.5% | 6.7% | CHF 48.00 | CHF 42.00 | CHF 29.15 | 2 |
Sep ’24 | CHF 31.65 | CHF 45.00 +42.2% | 6.7% | CHF 48.00 | CHF 42.00 | CHF 28.40 | 2 |
Aug ’24 | CHF 35.65 | CHF 46.00 +29.0% | 4.3% | CHF 48.00 | CHF 44.00 | CHF 29.20 | 2 |
Jul ’24 | CHF 34.15 | CHF 47.00 +37.6% | 6.4% | CHF 50.00 | CHF 44.00 | CHF 30.90 | 2 |
Jun ’24 | CHF 40.00 | CHF 57.50 +43.8% | 4.3% | CHF 60.00 | CHF 55.00 | CHF 31.50 | 2 |
May ’24 | CHF 41.50 | CHF 57.50 +38.6% | 4.3% | CHF 60.00 | CHF 55.00 | CHF 29.05 | 2 |
Apr ’24 | CHF 41.95 | CHF 57.50 +37.1% | 4.3% | CHF 60.00 | CHF 55.00 | CHF 29.10 | 2 |
Mar ’24 | CHF 45.05 | CHF 56.00 +24.3% | 7.1% | CHF 60.00 | CHF 52.00 | CHF 28.55 | 2 |
Feb ’24 | CHF 45.55 | CHF 58.50 +28.4% | 2.6% | CHF 60.00 | CHF 57.00 | CHF 27.25 | 2 |
Jan ’24 | CHF 46.85 | CHF 58.50 +24.9% | 2.6% | CHF 60.00 | CHF 57.00 | CHF 29.55 | 2 |
Dec ’23 | CHF 47.60 | CHF 58.50 +22.9% | 2.6% | CHF 60.00 | CHF 57.00 | CHF 28.50 | 2 |
Nov ’23 | CHF 42.65 | CHF 58.50 +37.2% | 2.6% | CHF 60.00 | CHF 57.00 | CHF 25.50 | 2 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.